Skip to content

The other side of the sword

Secondary malignancies in ALL survivors

From Hijiya et al., JAMA 2007: Chemotherapy for acute lymphoblastic leukemia is good. Very good. But it’s a two-edged sword. One side creates long-term cancer survivors. The other creates secondary malignancies in cancer survivors.

Post a Comment

Your email is never published nor shared. Required fields are marked *